Clinical Trials
The Center for Cancer Care participates in clinical trials that evaluate the effectiveness of new medications and therapies. Conducted by leading cancer research groups, as well as pharmaceutical companies, these trials can give you access to groundbreaking treatments that are not yet available to the general public - as well as a voice in determining the course of your care.
Several of the trials we participate in have advanced significantly in the FDA approval process. That means these treatments are not only promising - they're also helping to shape the future of cancer care.
Our current clinical trial opportunities include:
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Pancreatic Cancer
- Paroxysmal nocturnal hemoglobinuria (PNH)
- Supportive Care
Only your doctor can determine if you qualify for any of our current studies and whether participation would benefit you. This depends, in part, on the type of cancer you have and its stage. Staging describes the extent or severity of an individual's cancer based on the extent of the original (primary) tumor and the extent of spread in the body. Most cancers are grouped into the following stages:
- Stage 0 - The cancer is limited to the area in which it was found and has not spread to surrounding tissues.
- Stage I - The cancer is localized to one part of the body.
- Stage II and III - The cancer is locally advanced. (Whether a cancer is designated as Stage II or Stage III can depend on the specific type of cancer.)
- Stage IV - The cancer has spread to other organs or throughout the body.
If you qualify to join one of our clinical trials, you will be monitored by our physicians who are leaders in cancer research. To learn more about our current open studies, call our clinical research coordinator at 773-665-3109.
Call 877-RES-INFO (877-737-4636) to get a referral or schedule an appointment.
